Position in NVCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$625,431
-$39,442 QoQ
Shares Held
57,379
+11.6% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Tidal Investments LLC holds $160,406,040 across 30 Medical Devices names. NVCR ranks #22 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
329,444 | $33,824,013 | |
| 2 | MDT |
Medtronic plc
|
246,800 | $21,385,219 | |
| 3 | BSX |
Boston Scientific Corp
|
228,269 | $14,323,879 | |
| 4 | SYK |
Stryker Corp
|
40,652 | $13,357,840 | |
| 5 | PHG |
Koninklijke Philips NV
|
337,769 | $9,254,870 | |
| 6 | MASI |
Masimo Corp
|
49,720 | $8,843,694 | |
| 7 | EW |
Edwards Lifesciences Corp
|
102,209 | $8,184,896 | |
| 8 | PEN |
Penumbra Inc
|
23,646 | $7,764,636 |
All Filings in NVCR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $625,431 | 57,379 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $664,873 | 51,421 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $627,446 | 48,564 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $897,280 | 50,409 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $797,658 | 44,762 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,375,568 | 46,160 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $871,466 | 55,756 | Shares | Defined | 2024-11-25 | |
| 2024-06-30 | $912,874 | 53,291 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $695,003 | 44,466 | Shares | Defined | 2024-05-16 | |
| No filing history on record for this holder in this stock. | ||||||